Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

PDL BioPharma Inc (NASDAQ:PDLI)

3.20
Delayed Data
As of 4:00pm ET
 -0.09 / -2.74%
Today’s Change
2.58
Today|||52-Week Range
6.83
-9.60%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$602.7M

Company Description

PDL BioPharma, Inc. produces and markets biopharmaceutical products. It focuses on intellectual property asset management, investing in new royalty bearing assets and maximizing the value of its patent portfolio and related assets. The company manages a portfolio of patents and royalty assets, consisting of its Queen et al. patents, license agreements with various biotechnology and pharmaceutical companies, and royalty and other assets acquired. PDL BioPharma was founded by Cary L. Queen and Laurence Jay Korn in 1986 and is headquartered in Incline Village, NV.

Contact Information

PDL BioPharma, Inc.
932 Southwood Boulevard
Incline Village Nevada 89451
P:(775) 832-8500
Investor Relations:

Employees

Shareholders

Other institutional52.24%
Mutual fund holders30.76%
Individual stakeholders3.19%

Top Executives

John Peter McLaughlinPresident, Chief Executive Officer & Director
Peter S. GarciaChief Financial Officer & Vice President
Christopher Lewis StoneSecretary, Vice President & General Counsel
Danny J. HartVice President-Business Development
Steffen PietzkeChief Accounting Officer & Controller